These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 12891222)

  • 1. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Chen G; Weemhoff JL; Jen C; Kelley CJ; LeDuc BW; Zinny MA
    Clin Pharmacol Ther; 2003 Aug; 74(2):121-9. PubMed ID: 12891222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice.
    Farkas D; Oleson LE; Zhao Y; Harmatz JS; Zinny MA; Court MH; Greenblatt DJ
    J Clin Pharmacol; 2007 Mar; 47(3):286-94. PubMed ID: 17322140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: comparison with ritonavir.
    Culm-Merdek KE; von Moltke LL; Gan L; Horan KA; Reynolds R; Harmatz JS; Court MH; Greenblatt DJ
    Clin Pharmacol Ther; 2006 Mar; 79(3):243-54. PubMed ID: 16513448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
    Bailey DG; Dresser GK; Bend JR
    Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice.
    Veronese ML; Gillen LP; Burke JP; Dorval EP; Hauck WW; Pequignot E; Waldman SA; Greenberg HE
    J Clin Pharmacol; 2003 Aug; 43(8):831-9. PubMed ID: 12953340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
    Edwards DJ; Bellevue FH; Woster PM
    Drug Metab Dispos; 1996 Dec; 24(12):1287-90. PubMed ID: 8971132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-point sampling for assessment of constitutive, induced, and inhibited cytochrome P450 3A activity with alfentanil or midazolam.
    Chaobal HN; Kharasch ED
    Clin Pharmacol Ther; 2005 Nov; 78(5):529-39. PubMed ID: 16321619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
    Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.
    Malhotra S; Bailey DG; Paine MF; Watkins PB
    Clin Pharmacol Ther; 2001 Jan; 69(1):14-23. PubMed ID: 11180034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats.
    Hidaka M; Okumura M; Fujita K; Ogikubo T; Yamasaki K; Iwakiri T; Setoguchi N; Arimori K
    Drug Metab Dispos; 2005 May; 33(5):644-8. PubMed ID: 15673597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by CYP3A enzymes via in vivo and in vitro oxidation of midazolam and triazolam.
    Kuze J; Mutoh T; Takenaka T; Oda N; Hanioka N; Narimatsu S
    Xenobiotica; 2013 Jul; 43(7):598-606. PubMed ID: 23282066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2004 Sep; 76(3):250-69. PubMed ID: 15371986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins.
    Girennavar B; Jayaprakasha GK; Patil BS
    J Food Sci; 2007 Oct; 72(8):C417-21. PubMed ID: 17995595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance.
    Hukkanen J; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2006 Nov; 80(5):522-30. PubMed ID: 17112808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grapefruit juice intake does not enhance but rather protects against aflatoxin B1-induced liver DNA damage through a reduction in hepatic CYP3A activity.
    Miyata M; Takano H; Guo LQ; Nagata K; Yamazoe Y
    Carcinogenesis; 2004 Feb; 25(2):203-9. PubMed ID: 14578159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.
    Guo LQ; Fukuda K; Ohta T; Yamazoe Y
    Drug Metab Dispos; 2000 Jul; 28(7):766-71. PubMed ID: 10859150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.
    Kakar SM; Paine MF; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2004 Jun; 75(6):569-79. PubMed ID: 15179411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Low-Furanocoumarin Hybrid Grapefruit Juice Consumption on Midazolam Pharmacokinetics.
    Kawaguchi-Suzuki M; Nasiri-Kenari N; Shuster J; Gmitter FG; Cancalon P; de Oliveria F; Kight J; Handberg EM; Pepine CJ; Frye RF; Cooper-DeHoff RM
    J Clin Pharmacol; 2017 Mar; 57(3):305-311. PubMed ID: 27503364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.